In a study involving rats with AD-like symptoms, it was found that emodin, an AQ, lowered plaque Aβ levels and tau hyperphosphorylation by reducing BACE1 levels in the hippocampi and enhancing the activity of protein phosphatase 2A (PP2A). The gene discussed is PTPA; the disease is Alzheimer disease.